Clinical Trial Update: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of Phase 2 and Phase 3 trials assessing ilaprazole for treating duodenal ulcer in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Duodenal Ulcer | Phase 2, Phase 3 | Status: COMPLETED